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Abstract: Fluorine-containing organic scaffolds are of significant interest in medicinal chemistry.
The incorporation of fluorine into biomolecules can lead to remarkable changes in their physical,
chemical, and biological properties. There are already many drugs on the market, which contain
at least one fluorine atom. Saturated functionalized azaheterocycles as bioactive substances have
gained increasing attention in pharmaceutical chemistry. Due to the high biorelevance of
organofluorine molecules and the importance of N-heterocyclic compounds, selective stereo-
controlled procedures to the access of new fluorine-containing saturated N-heterocycles are
considered to be a hot research topic. This account summarizes the synthesis of functionalized
and fluorine-containing saturated azaheterocycles starting from functionalized cycloalkenes and
based on oxidative ring cleavage of diol intermediates followed by ring expansion with reductive
amination.
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1. Introduction
1.1. Importance of Functionalized Saturated
Azaheterocycles and Fluorinated Saturated N-heterocycles
Saturated azaheterocycles have gained increasing attention in
medicinal and organic chemistry. A large number of nitrogen-
containing saturated cyclic compounds are known as anti-
biotics, analgesics, antidepressants, anticancer, anti-HIV, and
anti-HCV agents.[1–3] According to the medicinal chemistry
literature, there are two main fields of interest with respect to
the structures of the present drug candidates: the popularity of
organofluorine scaffolds and of azaheterocycles.[4–9] Saturated
N-heterocycles are building blocks in synthetic bioactive
products and medicinal compounds. Five-, six-, and seven-
membered frameworks are the most common structural units.
In the development of new pharmaceuticals three-dimensional,
functionalized scaffolds with saturated building blocks, espe-
cially saturated N-heterocycles, are used preferably.[1–3] Figure 1
shows some representative N-heterocyclic structures with bio-
logical relevance.[10–14]
Fluorine-containing organic molecules (except only a few
representatives) are practically absent in nature, but they have
received significant interest in drug research. The replacement
of a hydrogen atom or a functional group by fluorine or a
fluorinated group could furnish biomolecules with unique
biological features. The incorporation of fluorine in biomole-
cules can lead to remarkable changes in their physical,
chemical, and pharmaceutical properties. There are already
many drugs on the market, which contain at least one fluorine
atom, and this number is expected to increase in years to
come.[15–17] Application of fluorinated compounds like fluo-
rine-containing amines could offer a route to the access of
fluorine-containing azaheterocycles.
Due to the high biorelevance of organofluorine scaffolds
and the importance of N-heterocyclic compounds, develop-
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ment of novel and efficient stereocontrolled procedures to the
access of new fluorine-containing saturated N-heterocycles is a
topic of high interest in synthetic organic chemistry. The
introduction of one or more fluorine atoms into molecules
may be achieved by starting from various functionalized
cycloalkenes. The transformations involved are oxidative ring
cleavage (olefin bond dihydoxylation, oxidative ring cleavage
of the diol intermediate) followed by ring expansion with
reductive amination, resulting in novel fluorine-containing N-
heterocycles.
Fluorine and the C  F bond have rather unique properties
and the incorporation of fluorine into a molecule may generate
unique changes, which cannot be attained by the use of any
other element.[16,17] It has great impact because a large number
of fluorine-containing substances are widely applied in various
areas like material sciences or medicinal and pharmaceutical
chemistry as well as agrochemistry.[18–21] The size of the
fluorine atom is very similar to that of hydrogen and fluorine
has the highest electronegativity. This could lead to increasing
lipophilicity and stability, and might furnish resistance to
metabolic transformations. The van der Waals radius of
fluorine is more similar to that of oxygen and the
carbon  fluorine bond length is comparable but weaker than
the carbon  oxygen bond. Hydrogen-bonding interactions may
provide special characteristics to the structure with at least one
fluorine atom. Due to these unique properties, it is a general
aim in drug design to furnish a biomolecule with fluorine or
fluorinated groups. There are an increasing number of drugs
on the market, which contain at least one fluorine atom
(Figure 2).[16,17,22–25]
Among organofluorine compounds of significant biorelev-
ance, saturated N-heterocyclic scaffolds with fluorine are of
special interest. Not surprisingly, the changing of an azahetero-
cycle motif into a fluorine-containing one can improve the
metabolic stability or reduce basicity, thereby providing better
bioavailability to a certain molecule. Fluorinated piperidines
and their derivatives exhibit promising biological activity
because of increased lipophilicity. β-Fluoroamine and tri-
fluoroamine moieties are also present in various fluorine-
containing derivatives with biological relevance (Figure 3).[4–7]
There has been a great interest in fluorine-containing
pyrrolidines or piperidines in pharmaceutical chemistry, which
are elements of various drugs.[26] Although fluorinated azepanes
are much less studied, they may also have wide attention in
pharmaceutical design in the future.[6,27] It is well known that
fluorine-containing tetrahydroisoquinoline derivatives, N-
bridged bicyclic frameworks, and other N-fluoroalkylated
molecular structures have great biological importance.[28–30]
Figure 1. Some bioactive functionalized N-heterocyclic compounds.
Figure 2. Several important representatives of fluorine-containing market leader drugs.
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2. Synthesis of Saturated N-heterocycles from
Dialdehyde Compounds
A large number of synthetic methodologies have been
developed to the access of azaheterocycles including aziridines,
azetidines, pyrrolidines, piperidines or azepanes.[31–35] In
organic and pharmaceutical chemistry, the creation of novel
saturated N-heterocycles is a field explored deeply. However,
due to the increasing importance of these scaffolds, the
development of novel, efficient, cost effective, selective, and
stereocontrolled protocols for these derivatives is a continuous
challenge in modern chemistry.[3a]
A simple and convenient method to obtain saturated
azaheterocycles is based on the transformation of cycloalkene
derivatives across oxidative ring opening, followed by reductive
amination of the diformyl intermediates.[3b]
The oxidative ring cleavage through the olefin bond of
unsaturated compounds is a widely applied, effective trans-
formation in organic chemistry to afford the corresponding
carbonyl compounds. There are two main methodologies in
the literature for oxidative ring opening: either through
ozonolysis of alkenes or cleavage of vicinal diols.[36–41] Both are
useful methods to prepare synthetically valuable dialdehydes or
diketones.[39] The Upjohn method is a two-step procedure for
the cleavage of the C  C double bond. First OsO4/NMO
produces the vicinal diol intermediate, which undergoes
further oxidation by the treatment of sodium periodate
(NaIO4) giving carbonyl compounds.[39] This procedure was
modified with the use of oxone in combination with OsO4
(Borhan and co-workers)[36a] or m-CPBA, HBF4 and ArI
(Ochiai et al.).[40] However, these procedures have limitations,
because of the forcing conditions used. Phenyliododiacetate
[PhI(OAc)2] is an efficient and selective reagent to cleave
vicinal diol derivatives providing aldehydes and ketones.[39]
Functionalized dialdehydes are valuable substrates, which
might be transformed into various substituted alicyclic,
heterocyclic or polysubstituted derivatives. The oxidative
synthetic approaches described above offer an opportunity for
the ring opening of several cycloalkene derivatives resulting in
the corresponding diformyl compounds. Nicolaou and co-
workers applied the ring-opening method for several cyclic
1,2-diol derivatives by PhI(OAc)2 in good yields.[39] Fricke
et al. reported the synthesis of iminodiacetaldehyde derivatives
from the corresponding 3,4-dihydroxypyrrolidines. The trans-
formation was based on diol production followed by oxidative
ring cleavage on treatment with Pb(OAc)4 or NaIO4 in
aqueous solution (Scheme 1).[41]
Since scaffolds possessing amino groups represent a large
and important class of pharmaceuticals and agrochemicals, the
creation of a C  N bonds has a great interest in organic
chemistry. There are several methodologies, but reductive
amination is the most impressive pathway for the formation of
a carbon  nitrogen bond in chemical industry.[42] This method,
also named reductive alkylation, involves the condensation of a
carbonyl compound with ammonia, primary or secondary
amines in the presence of a reducing agent.[43–45] The
introduction of a nitrogen atom into an organic molecule has
Figure 3. Fluorine-containing azaheterocyclic derivatives of biological importance.
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great potential in the synthesis of azaheterocycles or building
blocks in medicinal chemistry.
2.1. Transformation of Linear Dialdehydes into
N-heterocycles
Linear dialdehydes such as succinaldehyde or glutaraldehyde
are useful substrates for a number of transformations such as
aldol, Mannich, Michael and Henry reactions. These dialde-
hydes are often used for the rapid synthesis of frameworks with
medium-sized carbo- and hetero-cyclic ring systems.[3b] A
century ago Sir Robert Robinson applied a novel thinking in
the synthetic method and produced tropinone 23 in a one-pot
reaction by using succinaldehyde (20), primary amine (21),
and acetone dicarboxylic acid (22) (Scheme 2).[3b]
Xu and co-workers reported a diastereo- and enantio-
selective synthetic protocol by the application of glutaralde-
hyde (24) to produce N-heterocycles such as tetrahydropyr-
idines by using primary amine catalysis. A Mannich-type
reaction was developed, which gave 25 in an intramolecular
aqueous cyclization of glutaraldehyde, N-PMP aldimine 26
and proline (27) providing the corresponding tetrahydropyr-
idine derivative 28 (Scheme 3).[46]
Kumar et al. reported an extension of the above-described
procedure. Cycloaddition of glutaraldehyde (24) furnished
asymmetric 2,3-disubstituted piperidine framework (29) with
reduction in the last step (Scheme 4).[47]
Chen and co-workers described a synthetic pathway for the
preparation of azaheterocycles starting from aliphatic dialde-
hydes. The key steps of the synthetic procedure are an inverse
electron demand aza-Diels-Alder reaction (ADAR) followed by
an intramolecular hemiketal formation/oxidation reaction of
the N-Tos-1-aza-1,3-butadiene (30) and linear dialdehydes
Scheme 1. Synthesis of iminodiacetaldehyde 19.
Scheme 2. Synthesis of tropinone from succinaldehyde.
Scheme 3. Organocatalytic transformation of glutaraldehyde into optically active tetrahydropyridine.
Scheme 4. Functionalized piperidine synthesis through cycloaddition.
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(eg. glutaraldehyde). This multi-step process yielded lactone
[2,3-b]piperidine derivative 34 (Scheme 5).[48]
2.2. Transformation of Dialdehyde Derivatives into
Functionalized Azaheterocycles across Reductive
Amination
A number of methods was published for the synthesis of N-
heterocycles by the application of ring closing of linear
dialdehydes under reductive amination.[11,12,49–57]
Bols and co-workers developed a new method for the
synthesis of substituted hydroxypiperidines. The synthetic
process started from epoxide 35 affording hemiacetal 36 in a
two-step transformation. This was then submitted to reductive
amination with benzylamine. In the final steps, cleavage by
periodate gave enamine 38, which underwent hydrogenation
to deliver trans isomer 39 (Scheme 6).[11]
Chrick and co-workers developed a novel synthetic
protocol to the access of polyhydroxylated N-alkoxypiperidines
based on ring closing of dialdehydes by double-reductive
amination. The oxidative ring opening of olefin 40 was carried
out with OsO4/NaIO4 in dioxane and water resulting in cyclic
hydrate 41 in diastereomeric forms. In the following step,
double-reductive amination with benzylamine afforded the
desired piperidine derivative 42. This reaction was extended by
using alkoxyamines. Thus, O-benzylhydroxylamine was used
for the above-described double-reductive amination giving N-
alkoxypiperidine 43. The highest yield of 43 was attained by
using 2.5 equiv. of alkoxyamine (Scheme 7).[49] After the
optimization of this method, the synthesis of trisubstituted N-
alkoxypiperidine analogs of isofagomine was achieved.[49]
In another study, the synthesis of carbohydrate-derived
morpholine amino acids via oxidative cleavage and reductive
amination was described by Grotenberg et al. The synthetic
route started from commercial d-ribose 45, and the key step of
Scheme 5. Synthesis of a lactone[2,3-b]piperidine product via ADAR.
Scheme 6. Synthesis of substituted hydroxypiperidine derivative.
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the pathway were glycol cleavage of vicinal diol derivative 47
(derived from protected sugar amino acid derivative 46) with
HIO4. Double-reductive amination of the formed dialdehyde
48 furnished substituted morpholine amino acid derivatives
50a and 50b.[50a]
Reductive aminations were accomplished directly with
different amines including benzylamine at pH 5 (acidified
with AcOH) in the presence of NaBH3CN as reducing agent.
After purification, both diastereomeric morpholines were
isolated in 22% yield (Scheme 8).[50b] Herczegh and co-
workers applied the oxidative C  C cleavage/cyclization proto-
col to provide various so-called “tricyclanos” regarded as
conformationally constrained nucleoside analogues with a new
heterotricycle.[50b]
The method, based on oxidative ring cleavage and
reductive ring closure, is the key step in the synthesis of
morpholine oligomers. The thymine morpholino monomer
(52) was prepared from 5’-O-dimethoxytrityl ribothymidine
51 through oxidative ring cleavage with NaIO4 followed by
reductive amination with ammonium diborate. The formed
dihydroxythymine morpholino monomer intermediate was
reduced with NaBH3CN providing 52 (Scheme 9).[51] The
product formed is the key monomer in the design of
Eteplirsen.[58,59]
Azasugars (polyhydroxylated piperidines) exhibit significant
bioactivities. Shih et al. reported a synthetic procedure to
accomplish the synthesis of novel trihydroxypiperidine deriva-
tives starting with enone 53 synthetized from D-(  )-quinic
acid. The main steps of the procedure are oxidative ring
cleavage of the ring olefinic bond, intramolecular reductive
cyclization of the formed dialdehyde, and deprotection by Pd/
C/HCl leading to the required trihydroxy piperidine product
59 (Scheme 10).[52]
Scheme 7. Preparation of substituted piperidines with double-reductive amination.
Scheme 8. Synthesis of carbohydrate-derived morpholino amino acid derivatives.
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The synthesis of functionalized piperidine derivatives is
well-documented in the literature, whereas methods to
synthesize azepane compounds are much less reported. Lin and
co-workers described a new transformation for the synthesis of
tri- and tetra-hydroxyazepanes. Hydroxyazepanes are promis-
ing glycosidase inhibitors analogously to their five- or six-
membered analogs. The reported strategy is based on an
oxidative cleavage reaction and subsequent reductive cycliza-
tion.
In the first step, protected 1,4,5-cyclohex-2-ene-triols
derived from D-(  )-quinic acid underwent dihydroxylation by
the treatment of RuCl3/NaIO4. The resulting vicinal diols
(64–67) were further transformed via NaIO4-mediated oxida-
tive ring opening to afford the corresponding diformyl
compounds (68–71). The reductive cyclization was performed
with benzylamine in the presence of NaBH(OAc)3 as the
reducing agent (Scheme 11).[53]
This method was extended and further optimized for the
preparation of 7-hydroxymethyl-3,4,5-trihydroxyazepane (76).
The route, starting from a protected cyclohexenetriol, included
only three steps: ozonolysis, reductive amination, and depro-
tection (Scheme 12).[72,73]
Robinson et al. developed an effective synthesis of a series
of novel analogs of the antibacterial agent gemmacin B with a
bridged azepane framework (81). The key steps are oxidative
ring opening/ring closing through reductive amination
(Scheme 13).[60]
A novel and efficient stereocontrolled procedure for the
synthesis of tashiromine and epitashiromine alkaloids started
from cyclooctene-based β-lactam and involved an intramolec-
ular double reductive amination step of the diformyl
intermediates. Indolizidine alkaloids are highly important in
pharmaceutical chemistry, because they exhibit a wide range of
therapeutic activities such as anticancer, antimetastatic or
antitumor effects. The strategy for the synthesis of tashiromine
and epitashiromine alkaloids started from bicyclic β-lactam
(�)-82 and was based on the ring opening of the azetidinone
skeleton followed by the ring cleavage of the olefin double
bond of cyclooctene derivative (�)-84. The resulting crude
dialdehyde (�)-86 was submitted to catalytic hydrogenolysis
Scheme 9. Synthesis of thymine morpholino derivative 52.
Scheme 10. Synthesis of trihydroxy piperidine structure 59.
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and after N-deprotection a reduction via double intramolecular
cyclization gave the desired alkaloid (�)-88 (Scheme 14).[12]
The same method was successfully applied for the synthesis
of epitashiromine, a stereoisomers of tashiromine. The main
difference is the epimerization with NaOEt of cis-β-amino-
cyclohexenecarboxylate (�)-84 giving its C-1 epimer trans
amino ester (�)-89. The 1 :1 diastereoisomer mixture formed
in OsO4/NMO dihydroxylation of (�)-89 could not be
purified and next it was used in the ring-opening oxidation
and reductive cyclization steps. After the reduction of the ester
with LiAlH4, epitashiromine (�)-93 was isolated
(Scheme 15).[12]
Note, that the protocol is stereocontrolled, that is, in both
cases the configuration of the stereocenters of the starting cis
and trans esters (�)-84 and (�)-89 were conserved furnishing
the corresponding alkaloid epimers ((�)-88 and (�)-93).
An efficient stereocontrolled preparation was reported for
the introduction of a nitrogen atom into a cyclic β-amino acid.
The syntheses started from the readily available unsaturated
bicyclic β-lactams (�)-94, (�)-99, and (�)-100. Key steps of
the stereocontrolled synthetic pathways are the oxidative
cleavage of the ring olefin bond and subsequent reductive
amination with benzylamine. This method was applied for the
synthesis of both the racemic and enantiomerically pure
forms.[55–57]
The preparation of piperidine β-amino ester enantiomers
started from enantiomerically pure β-lactam (  )-94 (obtained
by enzymatic resolution of the racemate), which was submitted
to dihydroxylation with KMnO4. The next reaction step was
based on oxidative ring opening of the vicinal diol (97a,b)
mediated by NaIO4 followed by ring expansion giving novel
cis- and trans-β-aminocarboxylate scaffolds in enantiomerically
pure form (Scheme 16).[55]
Scheme 11. Synthesis of trihydroxylated azepanes 72 and 73.
Scheme 12. Synthesis of 7-hydroxymethyl-3,4,5-trihydroxyazepane.
P e r s o n a l A c c o u n t TH E CH EM I C A L R E CORD
Chem. Rec. 2019, 19, 1–23 © 2019 The Chemical Society of Japan & Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim Wiley Online Library 8
Similar transformations were applied for the regio- and
stereoisomeric synthesis of azepane β-amino esters
(Scheme 17).[56]
Azabicyclic β-amino esters were synthetized starting from
diendo- and diexo-norbornene β-amino acids with the above-
described ring-opening/ring-closure protocol. Racemic diendo
norbornane amino ester 105 as starting material provided
azaheterocyclic products 107 and 108 in a ratio of 1 :9. The
possible explanation for the formation of the isomeric mixture
is the keto  enol tautomerism of the diformyl derivatives,
which yielded a mixture of diendo and diexo azaheterocyclic
amino esters (Scheme 18).[57]
In a similar way, the synthetic pathway described above
was applied for the transformation of diexo-N-Boc-protected
norbornene β-amino ester 109. The oxidative ring-opening
Scheme 13. Synthesis of racemic gemmacin analogs.
Scheme 14. Synthesis of racemic tashiromine (�)-88.
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and reductive ring-closure methods provided azabicyclic β-
amino ester 107 (Scheme 19).[57]
3. Synthesis of Fluorine-containing Azaheterocycles
Taking into consideration of the high biorelevance of saturated
N-heterocycles[1–9] and organofluorine molecules,[15–17] the
combination of these molecular structures is a hot topic in
synthetic and medicinal chemistry. The synthetic methods
based on the oxidative ring opening of various substituted
cycloalkenes and unsaturated cyclic β-amino acid scaffolds
followed by cyclization of the diformyl intermediates under
reductive amination condition furnishes various N-heterocyclic
motifs incorporating fluorinated entities. The stereocontrolled
synthetic concept uses some fluorine-containing amines to
construct novel fluorine-containing azaheterocyclic com-
pounds.
Scheme 15. Synthesis of racemic epitashiromine (�)-93.
Scheme 16. Synthesis of piperidine-4-carboxylates in enantiomerically pure form.
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3.1. Synthesis of Fluorine-containing Functionalized
Piperidine Derivatives
The synthetic concept is based on the oxidative ring cleavage
of functionalized cycloalkenes, followed by ring closure via
reductive amination and, finally, ring expansion of the
diformyl intermediates.
3.1.1. Synthesis of Monosubstituted Fluorine-containing
Piperidines
Cyclopentenecarboxylic acid benzyl ester 110 was oxidized
with NMO/OsO4 yielding 1,2-cis-diol derivative (�)-111 as a
mixture of diastereoisomers in nearly 1 :1 ratio. However, in
the next oxidative ring-cleavage step, the stereocenters
disappear and, accordingly, the mixture of diastereoisomers
could be used in the next step without any difficulty. The
oxidation of this mixture mediated by NaIO4 furnished the
corresponding unstable linear dialdehyde 112, which was
immediately subjected to reductive amination. The oxidative
ring cleavage step was carried out with NaIO4 in THF/H2O.
Reductive ring closure was accomplished with commercially
available fluorine-containing amine 2,2,2-trifluoroethylamine
hydrochloride (Scheme 20).[61]
Reductive ring expansion was performed with diformyl
intermediate 112 and fluorine-containing amine and subse-
quent treatment with NaBH3CN in the presence of NaHCO3
and AcOH in EtOH, resulting in the corresponding
trifluoromethylated piperidine derivative 117 (Scheme 20).[61]
The synthetic approach could be applied by using other
fluorine-containing building blocks to accomplish the synthesis
of other fluorine-containing piperidines. Diformyl derivative
112 was treated with commercially available hydrochloride
salts of 2-fluoroethylamine or 2,2-difluoromethylamine fol-
lowed by reduction providing the corresponding mono- or
difluorinated piperidine derivatives (�)-118 and (�)-119
(Scheme 21).[61]
Cbz-protected amine 120 (synthesized from commercially
available cyclopent-3-enecarboxylic acid through Curtius re-
arrangement) underwent dihydroxylation giving a 1 :1 mixture
of vicinal diol derivatives (�)-121. This mixture was used in
the next step without separation of the diastereomers to yield
dialdehyde 122. Then it was used further without isolation via
double-reductive amination with 2,2,2-trifluoroethylamine in
the presence of NaBH3CN providing trifluoromethylated
piperidine 123 (Scheme 22).[61]
Scheme 17. Pathway to the access of regio- and stereoisomeric azepane amino esters.
Scheme 18. Synthesis of bridged azabicyclic β-amino ester stereoisomers 107
and 108.
Scheme 19. Synthesis of diexo azabicyclic β-amino ester 107.
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3.1.2. Synthesis of Fluorine-containing Piperidine β-amino
Esters
Due to their high biological potential, N-heterocyclic β-amino
acids are important motifs in pharmaceutical and organic
chemistry.[13] A number of fluorine-containing acyclic α- and
β-amino acids exhibit antitumoral or antibiotic
properties.[31a,62–64] Biomolecules containing β-fluorinated or β-
trifluorinated amine moieties are remarkable scaffolds in
medicinal chemistry or agrochemistry.[8,25,65,66] Thus, fluorine-
containing pyrrolidines and piperidines, which are present in
drug molecules, have enormous interest in medicinal
chemistry.[26,67–69] The application of the ring-opening/ring-
closing protocol has gained importance for the synthesis of
unsaturated β-amino acid derivatives as well.
Cyclopentene cis-β-amino esters (�)-124a,b were con-
verted to dihydroxylated cis amino esters (�)-126a,b by
NMO/OsO4-mediated dihydroxylation. These were then
Scheme 20. Synthesis of fluorine-containing piperidine derivative 117 from benzyl cyclopentenecarboxylate.
Scheme 21. Synthesis of fluorine-containing piperidine derivatives.
Scheme 22. Synthesis of functionalized piperidine derivative 123.
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reacted with NaIO4 in THF/H2O to form the corresponding
unstable open-chain dialdehyde amino esters (�)-127a,b.[55]
Reductive amination was achieved upon treatment with
commercially available 2,2,2-trifluoroethylamine hydrochloride
with NaBH3CN as reducing agent in the presence of NaHCO3
in EtOH. The substituents of the resulting (�)-128a,b β-
amino esters are bonded to the C-3 and C-4 atoms of the
piperidine framework in cis relationship (Scheme 23).[70]
The configuration of the chiral centers in (�)-128a,b is
predetermined by the structure of the starting materials, since
the C-1 and C-2 stereocenters of amino esters (�)-124a,b
were not affected during the ring expansion procedure.
Consequently, the cis amino ester gave the corresponding
piperidine derivative with the carboxylate and carbamate/
amide functions in a cis relative steric arrangement.[70]
Analogously, dihydroxylated amino esters (�)-129a,b with
the ester and the N-protected group in a trans relationship
were subjected to NaIO4-mediated oxidative ring cleavage.
The ring-closing procedure of the formed unstable diformyl
intermediates (�)-130a,b with trifluoroethylamine and
NaBH3CN afforded trans trifluoromethylated piperdine amino
esters (�)-131a,b (Scheme 23). Amino esters (�)-131a,b
were accessed via an alternative pathway by epimerization at
C-4 of (�)-128a,b with NaOEt in EtOH with the involve-
ment of the active methine group.[55,71–73]
By the variation of the starting fluorine-containing amine,
the synthetic concept could be readily extended to prepare
novel fluorine-containing piperidine β-amino acid derivatives.
An illustrative example is reductive amination either with 2-
fluoroethylamine hydrochloride or 2,2-difluoroethylamine
hydrochloride. Thus, dialdehyde (�)-127b was subjecteded to
reductive ring expansion on treatment with the above-
mentioned commercially available fluoroamines in the pres-
ence of NaHCO3 and NaBH3CN, providing the correspond-
ing monofluorinated and difluorinated piperidine β-amino
esters (�)-132 and (�)-133 (Scheme 24).[70]
3.2. Synthesis of Fluorine-containing Functionalized
Azepane Derivatives
The transformation of dialdehyde substrates could also be
applied for the construction of seven-membered functionalized
azaheterocyclic systems. Fluorine-containing azepane motifs
are described relatively less frequently in the literature than
their six-membered analogs. However, due to the important
role of various functionalized counterparts in drug design, they
may receive increasing attention in the future.[6,27]
Scheme 23. Synthesis of trifluoromethylated piperdine cis- and trans-β-amino ester frameworks.
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3.2.1. Synthesis of Monosubstituted Fluorine-containing
Azepane Derivatives
Because of the increasing importance of azepane structures, the
oxidative ring opening/reductive amination protocol was also
extended to the preparation of trifluoromethylated azepane
derivatives. Ethyl cyclohex-3-enecarboxylate (�)-134, a com-
mercially available product, was first submitted to dihydrox-
ylation to yield (�)-135 as a mixture of diol diastereoisomers
in a 1 :1 ratio. This dihydroxylated diastereoisomer mixture
could not be separated and, consequently, it was used further
in the next step. Thus, ring opening with NaIO4 gave the
corresponding open-chain dialdehyde (�)-136, which was
next converted on treatment with trifluorinated ethylamine
into azepane derivative (�)-137 (Scheme 25).[61]
The synthesis of a Cbz-protected fluorine-containing
azepane could be accomplished by starting from cyclohexene-
amine (�)-138 prepared by the Curtius reaction. Dihydrox-
ylation of (�)-138 afforded diol mixture (�)-139, which was
further converted by oxidative ring cleavage in the presence of
NaIO4. The unstable diformyl intermediate (�)-140 was
subjected to ring closure without isolation. The ring closure
was carried out by treatment with 2,2,2-trifluroethylamine
hydrochloride in EtOH, in the presence of NaHCO3 and
NaBH3CN and resulted in substituted azepane derivative (�)-
141 (Scheme 26). Note, that the formation of the seven-
membered framework provided lower yield in comparison
with those of the six-membered analogs.
3.2.2. Synthesis of Disubstituted Trifluoromethylated
Azepane Derivative
Commercially available cyclohexene cis-diester 142 was trans-
formed by dihydroxylation with OsO4/NMO furnishing
vicinal diol 143. Then NaIO4-mediated oxidative ring opening
of 143 followed by reductive ring expansion with trifluor-
oethylamine gave azepane diester 145 via the corresponding
dialdehyde intermediate 144 (Scheme 27).[61]
The configuration of the chiral centers in 145 is
predetermined by the structure of starting material 142, since
the stereocenters were not affected during the ring-expansion
procedure.
Scheme 24. Synthesis of monofluorinated and difluorinated piperidine β-amino esters (�)-132 and (�)-133.
Scheme 25. Synthesis of fluorine-containing azepane derivative (�)-137.
Scheme 26. Synthesis of fluorine-containing azepane derivative (�)-141.
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3.2.3. Synthesis of Fluorine-containing Azepane β-amino
Esters
The synthetic method was applied for the stereocontrolled
synthesis of trifluoromethylated azepane β-aminocarboxylates.
Thus, cis- and trans-2-aminocyclohex-4-enecarboxylates (�)-
146 and (�)-149 (derived from bicyclic β-lactam) were
oxidized with NMO/OsO4 yielding the corresponding vicinal
diol derivatives (�)-147 and (�)-150. In the forthcoming
step, these dihydroxylated esters were transformed into cis and
trans amino esters (�)-148 and (�)-151 possessing an azepane
ring. The reaction steps are oxidative ring opening and
stereocontrolled ring enlargement through reductive amination
with 2,2,2-trifluoroethylamine hydrochloride and NaBH3CN.
In the trifluoromethylated azepane compounds, the ring
nitrogen atom is in a distance of three carbon atoms from the
carbamate group (Scheme 28).[70]
The preparation of the regioisomers of trifluoromethylated
azepane derivatives (�)-148 and (�)-151 was also achieved.
N-Cbz protected ester (�)-152 subjected to epimerization
gave derivative (�)-155. Dihydroxylation of the C  C double
bond of these two compounds with NMO and OsO4 provided
vicinal diols (�)-153 and (�)-156. In the next step, both
dihydroxylated β-amino ester stereoisomers were subjected to
oxidative ring opening mediated by NaIO4 followed by
reductive ring expansion with trifluoroethylamine
hydrochloride furnishing cis and trans azepane amino esters
(�)-154 and (�)-157 [regioisomers of (�)-148 and (�)-
151]. In these products, the ring nitrogen atom is located at
two carbon atom distance from the carbamate group
(Scheme 29).[70]
3.2.4. Synthesis of Fluorine-containing Azabicyclic Azepane
Systems
Trifluoromethylated azabicyclic systems are of the high
physiological importance in medicinal chemistry. N-Hetero-
cyclic bicyclic α- and β-amino acids are key precursors of
medicinally important alkaloids, such as anatoxin-a, epibati-
dine, epiboxidine, and their analogs (Figure 4).[57]
Scheme 27. Synthesis of functionalized azepane derivative 145.
Scheme 28. Synthesis of azepane β-amino acid stereoisomers bearing a trifluormethyl group.
Figure 4.Medicinally important azabicyclic alkaloids.
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The commercially available diendo norbornene dicarbox-
ylate (�)-161 was transformed by dihydroxylation with OsO4
and NMO to diol derivative (�)-162. Subsequent oxidative
ring cleavage afforded unstable diformyl intermediate (�)-
163. The dialdehyde was transformed by reductive amination
with trifluoroethylamine hydrochloride in the presence of
NaBH3CN as reducing agent yielding N-bicyclic diester (�)-
164 (Scheme 30).[61]
N-Heterocyclic β-amino acids have gained wide attention
because of their incorporation into peptide structures.[13]
Commercially available diexo norbornene β-amino ester (�)-
165 was protected by Cbz  Cl to give (�)-166 followed by the
dihydroxylation step to form diol derivative (�)-167
(Scheme 31).
The oxidative ring cleavage of (�)-167 followed by
reductive amination with trifluoroethylamine hydrochloride
and NaBH3CN in the presence of NaHCO3 and AcOH
provided N-bicyclic amino ester (�)-168 (Scheme 31).
The stereocontrolled synthesis of the new azabridged
bicyclic β-amino ester containing the trifluoromethyl group
was also performed starting from diendo norbornene amino
ester (�)-169. Analogous to the synthetic approach for the
diexo isomer, N-Cbz-protection of (�)-169, dihydroxylation,
oxidative ring opening and ring enlargement across reductive
amination with trifluoroethylamine hydrochloride led to
compound (�)-172, a stereoisomer of (�)-168 (Scheme 32).
Taking into consideration the availability of a wide range
of cycloalkenes and those of functionalized primary amine
building blocks, the above-described convenient method might
be further applied towards the access of a series of functional-
ized azepane products.
Scheme 29. Synthesis of fluorine-containing cis and trans azepane β-amino esters.
Scheme 30. Synthesis of trifluoromethyl-containing azabicyclic diester (�)-164.
P e r s o n a l A c c o u n t TH E CH EM I C A L R E CORD
Chem. Rec. 2019, 19, 1–23 © 2019 The Chemical Society of Japan & Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim Wiley Online Library 16
3.3. Synthesis of Fluorine-containing
1,2,3,4-tetrahydro-isoquinoline Derivatives
The 1,2,3,4-tetrahydroisoquinoline skeleton (THIQ) has main
interest, because it is an important framework of a large
number of natural products. Most of them, for example,
alkaloids, exhibit a set of therapeutic activities. Several drugs,
such as some antidiuretics, antidepressants, hallucinogens and
antihypertensive agents, contain a THIQ motif.[74–79] Because
of these relevant properties, many synthetic approaches
towards the creation of an isoquinoline or THIQ core have
been described so far.[80–87] The well-known procedures are the
Pictet-Spengler, Bischer-Napieralski, and Pomeranz-Fritsch-
Bobbit cyclizations, which are widely-applied synthetic meth-
odologies to create a number of important isoquinoline
alkaloids.[80]
Fluorine-containing tetrahydroisoquinoline or isoquinoline
derivatives constitute an important area of fluorinated mole-
cules either as pharmaceuticals or agrochemicals.[88–90] The
preparation of fluorinated, fluoroalkylated, and fluoroarylated
isoquinoline derivatives with valuable biological properties
continues to be an area of high interest in medicinal chemistry.
Several methods for the creation of monofluorinated,
trifluoromethylated or fluoroarylated isoquinolines have been
developed in recent years.[88,89,91–93]
A novel and effective procedure for the synthesis of various
fluorinated 1,2,3,4-tetrahydroisoquinoline compounds has
been recently reported.[94] The developed production route was
a novel possibility to achieve the desired skeleton. The
synthetic path was based on further extension of the trans-
formations described above. It involves oxidative ring opening
and subsequent ring closing under reductive amination
conditions starting from indene and some substituted indene
derivatives. Key steps are oxidative ring cleavage of the olefin
bond through dihydroxylation/NaIO4-mediated oxidation and
subsequent ring closing with primary amines via reductive
amination. Unsubstituted 1H-indene 173 oxidized with
NMO/OsO4 furnished the corresponding vicinal diol deriva-
tive (�)-174. NaIO4-mediated oxidative ring opening of this
dihydroxylated compound afforded dialdehyde 175. This
diformyl intermediate was further transformed with some
Scheme 31. Synthesis of fluorinated N-bicyclic β-amino ester (�)-168.
Scheme 32. Synthesis of fluorinated N-bicyclic β-amino ester (�)-172.
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commercially available fluorine-containing primary amines to
provide the target compounds in two steps.
The reductive amination of 175 with 2-fluoroethylamine,
2,2-difluoroethylamine, and 2,2,2-trifluoroethylamine hydro-
chlorides, in the presence of NaBH3CN, yielded the corre-
sponding mono-, di- or trifluoromethyl tetrahydroisoquinoline
derivatives 176–178 (Scheme 33). The yield of the isoquino-
line derivatives decreased with the increasing number of
fluorine atoms in the amine molecules.
The synthetic approach could be extended to synthesize
other fluorinated and polyfluorinated tetrahydroisoquinoline
products. Vicinal diol (�)-174 subjected to oxidative ring
cleavage followed by treating the resulting dialdehyde (175)
with various commercially available trifluoromethylated or
polyfluorinated amines provided the corresponding azahetero-
cycles (179–182) (Table 1).[94]
A procedure was described by using a 1H-indene derivative
with substituent attached to the benzene moiety. 7-Bromo-
1H-indene 183 in the presence of OsO4 and NMO gave the
corresponding vicinal diol (�)-184. Oxidative ring opening
with NaIO4 gave unstable diformyl-substituted intermediate
185. Further reaction (reductive ring expansion) without
isolation with both 2,2,2-trifluoroethylamine and 2,2-difluor-
oethylamine under reductive conditions provided the corre-
sponding trifluorinated or difluorinated tetrahydroisoquinoline
derivatives 186 and 187 (Scheme 34).
The protocol was further extended for another selected
model compound, 2-methyl-1H-indene 188 with a substituent
Scheme 33. Novel synthetic method for the preparation of 1,2,3,4-tetrahydrisoquinoline compounds.
Scheme 34. Synthesis of N-heterocyclic frameworks from 7-bromo-1H-indene.
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at the five-membered ring of indene. Ring cleavage of diol 189
led to dicarbonyl derivative 190, which then underwent
reductive amination. Isoquinoline product (�)-191 was
created with trifluoroethyamine hydrochloride generating a
chiral center (Scheme 35).[94]
The generalization and extension of the developed pathway
was demonstrated by utilizing three different primary amines:
ethylamine (as the nonfluorinated counterpart of the mono-,
di- or trifluoroethylamines used earlier), butylamine (as an
alkylamine), and benzylamine (as an arylalkylamine). These
amines produced the corresponding N-substituted tetrahydroi-
soquinoline products. The above novel synthetic route offers
an alternative, simple and efficient procedure to the access of
THIQ frameworks[94] as well as other saturated azaheterocycles
such as γ-lactam[95] or more recently γ-amino acid
derivatives.[96]
4. Summary and Outlook
Simple, efficient, cost-effective synthetic methods are of main
interest for the creation of molecular libraries in drug research.
Oxidative ring opening of substituted cycloalkenes and ring
closing under reductive amination provide valuable three-
dimensional functionalized azaheterocycles. Readily available
functionalized cyclic olefins as starting materials are easily
transformed to valuable substituted dialdehydes. These can be
reacted further to access various types of substituted or
fluorine-containing highly functionalized fluorinated regio-
and stereoisomers of azaheterocycles as polysubstituted build-
ing blocks with multiple chiral centers with high chemical
diversity. The protocol involves stereocontrolled synthetic
methodologies, based on oxidative ring opening and fluorina-
tion of the diformyl intermediates either by using various
Table 1. Synthesis of fluorinated THIQ compound 179–182.
Diol Fluorine-containing amine Product Yield (%)
(two steps)
34
(179)
24
(180)
53
(181)
28
(182)
Scheme 35. Synthesis of N-heterocyclic framework (�)-191 from 2-methyl-
1H-indene.
P e r s o n a l A c c o u n t TH E CH EM I C A L R E CORD
Chem. Rec. 2019, 19, 1–23 © 2019 The Chemical Society of Japan & Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim Wiley Online Library 19
primary alkylamines or fluorine-containing amines. The
synthesized derivatives might be considered to be promising
scaffolds for drug design. They may also function as building
blocks in the synthesis of peptide research.
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PERSONAL ACCOUNT
Because of the high biorelevance of orga-
nofluorine molecules and the importance
of N-heterocyclic compounds, selective
stereocontrolled synthetic methodologies
to the access of new fluorine-containing
saturated azaheterocycles are considered
to be a hot topic of research. This
account summarizes the synthesis of
functionalized and fluorine-containing
saturated azaheterocyclic derivatives
starting from functionalized cycloalkenes
and based on oxidative ring opening of
diol intermediates followed by ring
expansion under reductive amination.
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1 – 23
Stereocontrolled Synthesis of Func-
tionalized Azaheterocycles from Car-
bocycles through Oxidative Ring
Opening/Reductive Ring Closing
Protocols
